阿里达摩院医疗AI模型入选国家级榜单

杭州日报12-18

本报讯（记者庄郑悦）近日，工业和信息化部联合国家药品监督管理局组织的2025年人工智能医疗器械创新任务揭榜挂帅入围单位公布，阿里达摩院牵头研发的“急性主动脉综合征CT图像智能辅助分诊软件”iAorta从1000余个申报项目中脱颖而出，成功入选。据悉，这是工业和信息化部、国家药监局自2021年首次联合开展人工智能医疗器械创新任务揭榜挂帅工作以来的第二次揭榜，旨在征集并遴选一批具备较强创新能力的单位...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2592893949?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-12-18 06:22","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2592893949","market":"us","top_or_hot":-1,"title":"阿里达摩院医疗AI模型入选国家级榜单","media":"杭州日报","content":"<div>\n<p>本报讯（记者 庄郑悦）近日，工业和信息化部联合国家药品监督管理局组织的2025年人工智能医疗器械创新任务揭榜挂帅入围单位公布，阿里达摩院牵头研发的“急性主动脉综合征CT图像智能辅助分诊软件”iAorta从1000余个申报项目中脱颖而出，成功入选。据悉，这是工业和信息化部、国家药监局自2021年首次联合开展人工智能医疗器械创新任务揭榜挂帅工作以来的第二次揭榜，旨在征集并遴选一批具备较强创新能力的单位...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251218062237a6af83bc&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>阿里达摩院医疗AI模型入选国家级榜单</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n阿里达摩院医疗AI模型入选国家级榜单\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-12-18 06:22 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251218062237a6af83bc&s=b><strong>杭州日报</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>本报讯（记者 庄郑悦）近日，工业和信息化部联合国家药品监督管理局组织的2025年人工智能医疗器械创新任务揭榜挂帅入围单位公布，阿里达摩院牵头研发的“急性主动脉综合征CT图像智能辅助分诊软件”iAorta从1000余个申报项目中脱颖而出，成功入选。据悉，这是工业和信息化部、国家药监局自2021年首次联合开展人工智能医疗器械创新任务揭榜挂帅工作以来的第二次揭榜，旨在征集并遴选一批具备较强创新能力的单位...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251218062237a6af83bc&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU0310800965.SGD","symbol_name":"FTIF - Templeton Global Balanced A Acc SGD","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251218062237a6af83bc&s=b","article_id":"2592893949","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251218062237a6af83bc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2592893949","pubTimestamp":1766010157,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"iAorta是阿里达摩院基于“平扫CT+AI”的领先技术，联合浙江大学医学院附属第一医院历时三年多研发出的AI模型，攻克了急性主动脉综合征漏诊、误诊频发的国际难题。下一步，达摩院将联合浙大一院在全国范围内推广iAorta模型。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"LU0310800965.SGD":"FTIF - Templeton Global Balanced A Acc SGD","LU0651946864.USD":"贝莱德新兴市场股票收益A2","LU1242518931.SGD":"Fullerton Lux Funds - Asia Absolute Alpha A Acc SGD","BK4548":"巴美列捷福持仓","LU1880383366.USD":"东方汇理中国股票基金 A2 (C)","LU1051768304.USD":"贝莱德新兴市场股票收益A6","LU0979878070.USD":"FULLERTON LUX FUNDS - ASIA ABSOLUTE ALPHA \"A\" (USD) ACC","LU1008478684.HKD":"UBS (LUX) EQUITY FUND -  CHINA OPPORTUNITY \"P\" (HKD) ACC","LU1515016050.SGD":"Blackrock Emerging Markets Equity Income A6 SGD-H","BABA":"阿里巴巴","BK4554":"元宇宙及AR概念","LU0661504455.SGD":"Blackrock Global Equity Income A5 SGD-H","LU1048596156.SGD":"Blackrock Asian Growth Leaders A2 SGD-H","BK4585":"ETF&股票定投概念","LU0545039389.USD":"BGF GLOBAL EQUITY INCOME \"A2\" ACC","LU1267930227.SGD":"TEMPLETON GLOBAL BALANCED \"AS\" (SGD) ACC A","BK4587":"ChatGPT概念","LU1152091168.USD":"UBS (LUX) EQUITY FUND - CHINA OPPORTUNITY (USD) \"PM\" INC","LU1046422090.SGD":"Fidelity Pacific A-SGD","BK4558":"双十一","LU0128525689.USD":"TEMPLETON GLOBAL BALANCED \"A\"(USD) ACC","LU0067412154.USD":"UBS (LUX) EQUITY FUND -  CHINA OPPORTUNITY \"P\" (USD) ACC","LU0501845795.SGD":"瑞银大中华区股票基金P Acc SGD","LU0052756011.USD":"TEMPLETON GLOBAL BALANCED \"A\" (USD) INC","BK4588":"碎股","BK4565":"NFT概念","LU1688375341.USD":"贝莱德中国灵活股票基金","LU1823568750.SGD":"Fidelity Global Technology A-ACC SGD","LU2148611432.USD":"AZ ALLOCATION BALANCED BRAVE \"AAZ\" (USDHDG) ACC","LU0797268264.HKD":"ALLIANZ TOTAL RETURN ASIAN EQUITY \"AT\" (HKD) ACC","IE00B0JY6N72.USD":"PINEBRIDGE GLOBAL EMERGING MARKETS FOCUS EQUITY \"A\" (USD) ACC","LU1235294995.USD":"FIDELITY GLOBAL TECHNOLOGY \"A\" (USDHDG) ACC","LU1769817096.USD":"UBS (LUX) EQUITY SICAV - GLOBAL EMERG MARKETS OPPO \"P\" (USD) INC","IE00BFMHRM44.USD":"NEUBERGER BERMAN GLOBAL EQUITY MEGATRENDS \"A\" (USD) ACC","BK4503":"景林资产持仓","LU1282648689.USD":"ALLIANZ TOTAL RETURN ASIAN EQUITY \"AMG\" (USD) INC","LU1769817179.HKD":"UBS (LUX) EQUITY SICAV - GLOBAL EMERG MARKETS OPPO \"P\" (HKD) INC","LU0348816934.USD":"ALLIANZ TOTAL RETURN ASIAN EQUITY \"AT\" (USD)","BK4502":"阿里概念","BK4505":"高瓴资本持仓","LU0047713382.USD":"BGF EMERGING MARKETS \"A2\" ACC","BK4504":"桥水持仓","LU1051769294.HKD":"BGF EMERGING MARKETS EQUITY INCOME \"A6\"(HKDHDG) INC","LU1152091754.HKD":"UBS (LUX) EQUITY FUND - CHINA OPPORTUNITY (USD) \"PM\" (HKD) INC","LU2226246903.HKD":"ALLIANZ TOTAL RETURN ASIAN EQUITY \"AT4\" (HKD) ACC","LU1048588211.SGD":"Blackrock Asian Dragon A2 SGD-H","LU0072462343.USD":"贝莱德亚洲巨龙基金","BK4607":"DeepSeek概念股","LU0072913022.USD":"UBS (LUX) EQUITY FUND -  GREATER CHINA \"P\" (USD) ACC","BK4524":"宅经济概念","BK4220":"综合零售","LU1105468828.SGD":"Allianz Total Return Asian Equity AM DIS H2-SGD","BK4527":"明星科技股","LU0918141705.HKD":"ALLIANZ TOTAL RETURN ASIAN EQUITY \"AM\" (HKD) INC","BK4526":"热门中概股","LU0106959298.USD":"UBS (LUX) EQUITY FUND - EMERGING MARKETS SUSTAINABLE LEADERS (USD) \"P\" (USD) ACC","LU1242518857.USD":"FULLERTON LUX FUNDS - ASIA ABSOLUTE ALPHA \"I\" (USD) ACC","LU0821914370.USD":"贝莱德亚洲成长领袖A2","BK4122":"互联网与直销零售","BK4575":"芯片概念","LU0651947912.USD":"BGF EMERGING MARKETS EQUITY INCOME \"A5G\" (USD) INC","BK4614":"Manus概念股","BK4579":"人工智能","LU0328353924.USD":"UBS (LUX) EQUITY SICAV - GLOBAL EMERGING MARKETS OPPORTUNITY (USD) \"P\" (USD) ACC","LU0949170772.SGD":"Blackrock Global Equity Income A6 SGD-H","LU1003077747.HKD":"BGF GLOBAL EQUITY INCOME \"A6\" (HKDHDG) INC","IE00BF5LJ272.USD":"Legg Mason Martin Currie - Global Emerging Markets A Acc USD","LU0553294199.USD":"BGF GLOBAL EQUITY INCOME \"A5G\" (USD) INC","BK4581":"高盛持仓","LU0880133367.SGD":"UBS (LUX) EQUITY FUND CHINA OPPORTUNITY USD \"P\" (SGD) ACC","09988":"阿里巴巴-W","BK4543":"AI","BK4531":"中概回港概念","LU0918141887.USD":"安联亚洲实际收益股票基金","LU0738911758.USD":"Blackrock Global Equity Income A6 USD","BK4534":"瑞士信贷持仓","LU0348814723.USD":"ALLIANZ TOTAL RETURN ASIAN EQUITY \"A\" (USD) INC  NC","BK4533":"AQR资本管理(全球第二大对冲基金)","LU0251143458.SGD":"Fidelity Emerging Markets A-SGD","LU1046421795.USD":"富达环球科技A-ACC","BK4535":"淡马锡持仓","BK4538":"云计算"},"translate_title":"Alibaba Damo Academy's medical AI model was selected into the national list","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"09988":1.88,"ALBmain":0.6,"BABA":1.88},"content_text":"本报讯（记者 庄郑悦）近日，工业和信息化部联合国家药品监督管理局组织的2025年人工智能医疗器械创新任务揭榜挂帅入围单位公布，阿里达摩院牵头研发的“急性主动脉综合征CT图像智能辅助分诊软件”iAorta从1000余个申报项目中脱颖而出，成功入选。据悉，这是工业和信息化部、国家药监局自2021年首次联合开展人工智能医疗器械创新任务揭榜挂帅工作以来的第二次揭榜，旨在征集并遴选一批具备较强创新能力的单位集中攻关，加速新技术和新产品的落地应用，更好地服务和保障人民群众生命健康。人工智能技术与医疗器械正在加速融合发展。iAorta是阿里达摩院基于“平扫CT+AI”的领先技术，联合浙江大学医学院附属第一医院（下称浙大一院）历时三年多研发出的AI模型，攻克了急性主动脉综合征（AAS）漏诊、误诊频发的国际难题。公开资料显示，包括主动脉夹层在内的急性主动脉综合征是一类危急的心血管疾病，发病24小时内死亡率可达30%，但很难在第一时间确诊。iAorta模型能在常规平扫CT的基础上快速勾画出主动脉及其血管腔，判断血管壁有无结构变化，从而精准识别AAS。在20万人的大规模临床试验中，iAorta模型的敏感性和特异性分别达到95.5%和99.4%，可将AAS的漏诊率从48.8%显著降低至4.8%，平均确诊时间从4.3小时缩短至1.7小时。例如，在某三甲医院部署iAorta大模型后，一名43岁患者因“上腹部钝痛12小时”入院，医生初诊考虑胆囊结石并开具上腹部平扫CT检查，iAorta模型立即提示主动脉夹层，帮助患者在1.6小时内确诊。相关专家表示，该AI模型所需检查手段仅为常规平扫CT，偏远地区和基层医院无需额外采购设备即可部署，具有重大的医疗普惠意义。下一步，达摩院将联合浙大一院在全国范围内推广iAorta模型。目前，浙大一院、浙江医院、宁波市第二医院、温州市中心医院、湖州市中心医院、绍兴市中心医院、衢州市人民医院、安吉人民医院、衢州市柯城区人民医院、台州市三门县人民医院等浙江首批10家医院，以及山东省立医院等多家省外医院已率先开展iAorta大模型科研合作落地。","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"productRelease","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":1,"commentSize":0,"repostSize":0,"favoriteSize":1,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2592893949","isCrawlerRequest":true}